Multiples PE to acquire 10% stake in BDR Pharma for Rs.750-Cr: report

Private Equity firm Multiples is to invest around INR 750 crore to acquire an about 10% stake in Mumbai-based generic drugs maker BDR Pharmaceuticals. O3 Capital is the sell side financial advisor on the deal. Last month, BDR began manufacturing oral anti-Covid pill Molulife (molnupiravir) in the country, joining hands with Mankind Pharma. It had posted a revenue of INR 1,200 crore and Ebitda of INR 400 crore for FY21.